Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...

Test your eyesight and colour vision with this fun optical illusion challenge. Spot the hidden number in a colourful circle ...

Shares of MeiraGTx Holdings shares reached a 52-week high after the company said 11 children treated to date in a drug study gained visual acuity after treatment. The stock was recently up 9.1%, to $7 ...

MeiraGTx stock rose after publishing promising results from the first human trial using gene therapy to treat ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Holdings announced the publication of results from the first-in-human interventional study to treat children with ...

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

Ocular surface disease is a common condition characterized by abnormalities in the tear film and ocular surface, resulting in ...

Orlando, FL - Micro Medical Devices (MMD), a longstanding innovator in the field of ophthalmic diagnostic technology, is set to showcase its latest advancements at Vision Expo East 2025 in Orlando, ...

Topline results for COAST are anticipated in early Q2 2025, with ShORe results expected mid-2025.